SFDA Approves China Medical Technologies’ HPV Test

China Medical Technologies (中国医疗技术公司) reported that its SPR-based HPV-DNA chip has been approved by the SFDA. The fully automated machine is capable of identifying the 16 high-risk HPV subtypes and 8 low-risk variations as well as viral load. Human papillomavirus is a common virus that can lead to warts as well as cervical cancer. More details... Stock Symbol: (NSDQ: CMED)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.